A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, ASCENDING-DOSE, SAFETY STUDY OF CC-220 IN SUBJECTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

被引：1
|
作者：
Werth, V. P. [1 ]
Furie, R. [2 ]
Korish, S. [3 ]
Weiswasser, M. [3 ]
Azaryan, A. [3 ]
Schafer, P. H. [3 ]
Delev, N. [3 ]
Choi, S. [3 ]
Hough, D. [3 ]
机构：
[1] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[2] Northwell Hlth, Great Neck, NY USA
[3] Celgene Corp, Summit, NJ USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.3546
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0255
引用
收藏
页码：870 / 871
页数：2
相关论文
共 50 条
  • [31] Safety and tolerance of methylnaltrexone in healthy humans: A randomized, placebo-controlled, intravenous, ascending-dose, pharmacokinetic study
    Foss, JF
    OConnor, M
    Yuan, CS
    Murphy, M
    Moss, J
    Roizen, MF
    JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (01): : 25 - 30
  • [32] Respiratory Safety of Lemborexant in Healthy Subjects: A Single-Dose, Randomized, Double-Blind, Placebo-Controlled, Crossover Study
    Cheng, Jocelyn Y.
    Moline, Margaret
    Zammit, Gary K.
    Filippov, Gleb
    Bsharat, Mohammad
    Hall, Nancy
    CLINICAL DRUG INVESTIGATION, 2021, 41 (05) : 449 - 457
  • [33] Respiratory Safety of Lemborexant in Healthy Subjects: A Single-Dose, Randomized, Double-Blind, Placebo-Controlled, Crossover Study
    Jocelyn Y. Cheng
    Margaret Moline
    Gary K. Zammit
    Gleb Filippov
    Mohammad Bsharat
    Nancy Hall
    Clinical Drug Investigation, 2021, 41 : 449 - 457
  • [34] Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
    Wallace, Daniel J.
    Furie, Richard A.
    Tanaka, Yoshiya
    Kalunian, Kenneth C.
    Mosca, Marta
    Petri, Michelle A.
    Doerner, Thomas
    Cardiel, Mario H.
    Bruce, Ian N.
    Gomez, Elisa
    Carmack, Tara
    DeLozier, Amy M.
    Janes, Jonathan M.
    Linnik, Matthew D.
    de Bono, Stephanie
    Silk, Maria E.
    Hoffman, Robert W.
    LANCET, 2018, 392 (10143): : 222 - 231
  • [35] A Double-Blind, Placebo-Controlled, Ascending-Dose, Randomized Study to Evaluate the Safety, Tolerability and Effects on Cognition of AL-108 after 12 Weeks of Intranasal Administration in Subjects with Mild Cognitive Impairment
    Morimoto, Bruce H.
    Schmechel, Don
    Hirman, Joe
    Blackwell, Andrew
    Keith, Julian
    Gold, Michael
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2013, 35 (5-6) : 325 - 339
  • [36] Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial
    He, Jing
    Zhang, Ruijun
    Shao, Miao
    Zhao, Xiaozhen
    Miao, Miao
    Chen, Jiali
    Liu, Jiajia
    Zhang, Xiaoying
    Zhang, Xia
    Jin, Yuebo
    Wang, Yu
    Zhang, Shilei
    Zhu, Lei
    Jacob, Alexander
    Jia, Rulin
    You, Xujie
    Li, Xue
    Li, Chun
    Zhou, Yunshan
    Yang, Yue
    Ye, Hua
    Liu, Yanying
    Su, Yin
    Shen, Nan
    Alexander, Jessy
    Guo, Jianping
    Ambrus, Julian
    Lin, Xin
    Yu, Di
    Sun, Xiaolin
    Li, Zhanguo
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (01) : 141 - 149
  • [37] A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Ascending Multiple Oral Doses of CC 930 in Healthy Volunteers
    Kong, Linghui
    Ye, Ying
    Liu, Liangang
    Reyes, Josephine
    Wan, Yuntao
    Wu, Anfan
    Lau, Henry
    Laskin, Oscar
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (09): : 1343 - 1343
  • [38] LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus -: Results from a randomized, double-blind, placebo-controlled study
    Alarcón-Segovia, D
    Tumlin, JA
    Furie, RA
    McKay, JD
    Cardiel, MH
    Strand, V
    Bagin, RG
    Linnik, MD
    Hepburn, B
    ARTHRITIS AND RHEUMATISM, 2003, 48 (02): : 442 - 454
  • [39] Safety and tolerability of high-dose ulinastatin after 2-hour intravenous infusion in adult healthy Chinese volunteers: A randomized, double-blind, placebo-controlled, ascending-dose study
    Chen, Qian
    Hu, Chaoying
    Liu, Ye
    Liu, Yun
    Wang, Wei
    Zheng, Hongchao
    Rong, Lianchen
    Jia, Jingying
    Sun, Shixuan
    Yu, Chen
    Liu, Yan Mei
    PLOS ONE, 2017, 12 (05):
  • [40] A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multiple-Dose Study to Evaluate AMG 557 in Patients With Systemic Lupus Erythematosus and Active Lupus Arthritis
    Cheng, Laurence E.
    Amoura, Zahir
    Cheah, Benjamin
    Hiepe, Falk
    Sullivan, Barbara A.
    Zhou, Lei
    Arnold, Gregory E.
    Tsuji, Wayne H.
    Merrill, Joan T.
    Chung, James B.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70 (07) : 1071 - 1076
12345